Korea’s Chemizon Expands Beijing Operations
This article was originally published in PharmAsia News
SHANGHAI - Chemizon received board approval to invest $5 million in 2008 in its Beijing-based subsidiary, the company announced Aug. 6
You may also be interested in...
SEOUL - South Korean Optomagic subsidiary Chemizon signed a drug development cooperation agreement with China's Shenogen Pharma Group for small molecule therapeutics targeting modulators of the estrogen receptor alpha 36
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).